`

Our story

Innovating an Industry

Since 2012, we have been developing a solution that avoids the need for open brain surgery by using a minimally-invasive procedure.

Screen Shot 2022 06 09 at 9 34 10 AM

Quick facts about us

01

The device, the stentrode™, is 8mm in diameter and made from a flexible alloy called nitinol. It is inserted into Superior Sagittal Sinus in the brain via the jugular vein.

02

Initial grant funding was provided to a lab in the University of Melbourne by the U.S. Defense Advanced Research Projects Agency (DARPA) and Department of Defense (DoD).

03

In 2020, FDA awarded the stentrode™ the Breakthrough Device Designation. In 2021, Synchron became the first company to receive an FDA IDE to conduct trials of a permanently implantable BCI.

04

Series B funding was led by Khosla Ventures, with total capital raised now of $70M, including support from the U.S. and Australian governments.

05

Synchron is headquartered in Brooklyn, New York, and has an office in Melbourne, Australia.

Leadership Team

We’re a global team of scientists, innovators, and future-thinkers.

Tom Oxley CEO

Tom Oxley

CEO

Nick Opie CTO

Nick Opie

CTO

Amos Meltzer CLO

Amos Meltzer

Chief Legal Officer

Employee Mocco

J Mocco

Chief Medical Officer

Thumbnail Kurt

Kurt Haggstrom

Chief Commercial Officer

Gary Castro VP Finance

Gary Castro

VP, Finance

Riki Banerjee VP RD

Riki Banerjee

VP, R&D

Peter Yoo Senior Director of Neuroscience

Peter Yoo

Senior Director, Neuroscience

Edward Karst Senior Director of Clinical Regulatory

Edward Karst

Senior Director, Clinical & Regulatory

Gil Rind Director of Advanced Technologies

Gil Rind

Director, Advanced Tech

Darragh Mc Dermott Director of Hardware

Darragh McDermott

Director, Hardware

Rina

Rina Bhagat

Director, Quality & Regulatory

Amanda Zwarenstein Director of Product 1

Amanda Zwarenstein

Director, Product

Chloe Brown Director of Marketing

Chloe Brown

Director, Strategic Marketing

Microsoft Teams image modified

Kimberly Ha

Communications Lead

Awards

Partners

Board

Advisors

The Best Inventions of 2021

Time Magazine

2021

Next Big Things in Tech

Fast Company

2021

Most Disruptive Innovator Award

Newsweek

2021

Innovation Award

Society of Vascular and Neurointerventional Neurology

2021

BCI Award

BCI Award Foundation

2021

Innovator of the Year Finalist

Gentlemen’s Quarterly

2019

Advance Global Overall Australian of the Year

Advance Awards

2019

UNSW Eureka Prize for Excellence in Interdisciplinary Scientific Research

Australian Museum

2019

Innovator of the Year Finalist

Congress of Neurological Surgeons

2018

Khosla Ventures

Neuro Technology Investors

Metis Innovative

Rahul P Sharma, MD

Director Cath Lab, Interventional Cardiology, Stanford

Alex Morgan, MD, PhD

Partner, Khosla Ventures

Martin Dieck, Chairman

Managing Member, Neuro Technology Investors

Eddie Chang, MD

Chair, Dept of Neurosurgery UCSF

Tim Denison, PhD

Royal Academy Chair, Oxford University

Jordi Parramon, PhD

President, Google Verily

Earl Slee

VP, Medtronic (retired)

Victor Rodrigues

VP, Cochlear

Marc Slutzky, MD, PhD

Professor, Northwestern University

Josh Duyan

Investor, Artisan Partners

Check out our published research to learn more about our work.